Advertisement

Research Article Free access | 10.1172/JCI1597

The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells.

G Teoh, M Urashima, EA Greenfield, KA Nguyen, JF Lee, D Chauhan, A Ogata, SP Treon, and KC Anderson

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Teoh, G. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Urashima, M. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Greenfield, E. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Nguyen, K. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Lee, J. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Chauhan, D. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Ogata, A. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Treon, S. in: JCI | PubMed | Google Scholar

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA.

Find articles by Anderson, K. in: JCI | PubMed | Google Scholar

Published March 15, 1998 - More info

Published in Volume 101, Issue 6 on March 15, 1998
J Clin Invest. 1998;101(6):1379–1388. https://doi.org/10.1172/JCI1597.
© 1998 The American Society for Clinical Investigation
Published March 15, 1998 - Version history
View PDF
Abstract

Previous studies have shown that triggering multiple myeloma (MM) cells via CD40 induces IL-6-mediated autocrine growth as well as increased expression of cell surface adhesion molecules including CD11a, CD11b, CD11c, and CD18. In this study, we generated the 5E2 mAb which targets an antigen that is induced upon CD40 ligand (CD40L) activation of MM cells. Immunofluorescence, immunoprecipitation, and protein sequencing studies identified the target antigen of 5E2 mAb as the 86-kD subunit of the Ku autoantigen. We demonstrate that increased cell surface expression of Ku on CD40L-treated cells is due to migration of Ku from the cytoplasm to the cell surface membrane. Moreover, cell surface Ku on CD40L-treated MM cells mediates homotypic adhesion of tumor cells, as well as heterotypic adhesion of tumor cells to bone marrow stromal cells and to human fibronectin; and 5E2 mAb abrogates IL-6 secretion triggered by tumor cell adherence to bone marrow stromal cells. These data suggest that CD40L treatment induces a shift of Ku from the cytoplasm to the cell surface, and are the first to show that Ku functions as an adhesion molecule. They further suggest that cell surface Ku may play a role in both autocrine and paracrine IL-6-mediated MM cell growth and survival.

Version history
  • Version 1 (March 15, 1998): No description
Advertisement
Advertisement